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ABSTRACT The two major disease-causing biotypes of
Vibrio cholerae, classical and El Tor, exhibit differences in
their epidemic nature. Their behavior in the laboratory also
differs in that El Tor strains produce two major virulence
factors, cholera toxin (CT) and the toxin coregulated pilus
(TCP), only under very restricted growth conditions, whereas
classical strains do so in standard laboratory medium. Ex-
pression of toxin and TCP is controlled by two activator
proteins, ToxR and ToxT, that operate in cascade fashion with
ToxR controlling the synthesis of ToxT. Both biotypes express
equivalent levels of ToxR, but only classical strains appear to
express ToxT when grown in standard medium. In this report
we show that restrictive expression of CT and TCP can be
overcome in El Tor strains by expressing toxT independently
of ToxR. An El Tor strain lacking functional ToxT does not
express CT or TCP, ruling out existence of a cryptic pathway
for virulence regulation in this biotype. These results may have
implications for understanding the evolution of El Tor strains
toward reduced virulence with respect to classical strains.
Vibrio cholerae causes the human diarrheal disease cholera.
Epidemic strains of V. cholerae are classified into two biotypes,
classical and El Tor. Much of the world is currently experi-
encing an El Tor pandemic, unlike at least the two previous
cholera pandemics that were classical pandemics (1). In addi-
tion, strains of the atypical 0139 serogroup, responsible for
outbreaks of cholera beginning in 1993, are derivatives of El
Tor strains (2). The biotype classification is based on biochem-
ical differences including susceptibility to polymixin B, hem-
agglutination of chicken erythrocytes, hemolysis of sheep
erythrocytes, and the Voges-Proskauer test, which measures
the production of acetylmethylcarbinol (3). Although the
biotype definition is essentially bacteriological, differences in
the epidemic nature of the biotypes also exist. While both
classical and El Tor strains of V. cholerae have epidemic
potential, classical strains are associated with more severe
infection. In one study it was estimated that a severe outcome
(i.e., frank cholera) accounted for 11% of infection with
classical strains, whereas only 2% of infections with El Tor
strains resulted in severe disease (3).
The ability of V. cholerae to cause disease is due to produc-
tion of the cholera toxin (CT), an ADP-ribosylating toxin that
disrupts cAMP metabolism in intestinal cells leading to secre-
tory diarrhea in cholera patients. Several other virulence genes
have been identified in V. cholerae and many of these are
expressed coordinately with the genes encoding the CT. In-
cluded among these are the genes encoding the toxin coregu-
lated pilus (TCP), a fimbrial structure on the surface of the
bacteria that is required for colonization (4, 5). While the pilus
is made up primarily of a single subunit, TcpA, its assembly
requires the productsof several genes linked to tcpA, and these
also are coordinately expressed with CT (6, 7).
Coordinate expression of CT and TCP is controlled by the
ToxR regulatory protein. The current model for virulence
regulation by ToxR is that of a cascade in which ToxR controls
expression of another regulator, ToxT, and ToxT directly
controls expression of virulence genes (8). The ToxR cascade
is modulated by growth signals such that certain conditions
result in high level expression of ToxR-regulated genes,
whereas other conditions do not. There are marked differences
in the regulation of the ToxR cascade between the two
biotypes. Classical strains express high levels of toxin and TCP
in standard laboratory medium when cultivated at 25-30°C (5,
9, 10). El Tor strains, by contrast, require growth under special
conditions, termed AKI, for high-level expression of ToxR-
regulated genes (11, 12). Under the AKI conditions, organisms
are cultivated for several hours in bicarbonate without aera-
tion, followed by several hours of growth with vigorous aera-
tion (11, 12, 28).
The substantially different way that classical and El Tor
strains regulate production of virulence factors in response to
in vitro growth may in part account for the observations
described above regarding their epidemic behavior. We hy-
pothesize that differences in virulence regulation between the
two biotypes are associated with the way that ToxT is regulated
in the two biotypes. In this report, we show that high-level
production of toxin and TCP by El Tor strains under normally
nonpermissive conditions can be achieved if expression of the
toxTgene is removed from ToxR control. This suggests that the
basis for the regulatory difference between classical and El Tor
V. cholerae is expression of the toxT gene.
MATERIALS AND METHODS
Bacterial Strains and Media. Strains were stored in 20%
glycerol at -70°C and inoculated onto plate medium prior to
growth in liquid culture. Luria broth (LB) was made with
tryptone (10 g/liter), yeast extract (5 g/liter), and NaCl (5
g/liter). TCBS agar medium, which is selective for Vibrio spp.
(Difco) was prepared according to supplier's instructions.
Growth of V cholerae in LB was done overnight at 30°C on a
tube roller. AKI conditions were as described (11, 13). Am-
picillin and kanamycin were used at final concentrations of 100
,ug/ml and 30 ,ug/ml, respectively.
Immunoblot Analysis of TcpA and ToxR, CT ELISA, and
Primer Extension. Preparation of samples for immunoblot
analysis was done as described (14). Samples were subjected to
Abbreviations: CT, cholera toxin; TCP, toxin coregulated pilus; IPTG,
isopropyl f3-D-thiogalactoside; MSHA, mannose-sensitive hemagglu-
tinin.
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SDS/PAGE electrophoresis followed by blotting to nitrocel-
lulose paper for 2 h using a Hoefer semi-dry blotting appara-
tus. Parallel gels loaded with the same sample volumes were
electrophoresed and stained with Coomassie brilliant blue to
ensure equal loading on the blotted gel. Blots were incubated
for 2 h to overnight in 5% milk/20 mM Tris.HCl/0.5 M NaCl
(pH 7; TBS) with a 1:2000 dilution of rabbit polyclonal
anti-TCP serum or anti-ToxR serum (supplied by J. Mekala-
nos, Harvard Medical School). After washing for 15 min with
three changes of TBS, blots were incubated for 2-4 h with 5%
milk/TBS and a 1:5000 dilution of goat anti-rabbit IgG linked
to alkaline phosphatase. After washing in TBS, blots were
developed in 1 M Tris HCl, pH 9.0/5-bromo-4-chloro-3-
indolyl phosphate (Sigma; 40 ,ug/ml)/nitroblue tetrazolium
(Sigma; 100 ,tg/ml).
Culture supernatant fractions were analyzed for CT pro-
duction by GM1-ELISA as described (15) using monoclonal or
polyclonal sera supplied by M. Bagdasarian (Michigan State
University). Values for toxin production are given as concen-
tration of toxin per OD600 of the culture.
RNA was isolated using the Tri-Reagent (Molecular Re-
search Center, Cincinnati) following the manufacturer's pro-
tocol. Cultures were grown overnight, subcultured at 1:10 into
fresh medium, and grown for 2-3 h prior to harvesting the cells
for RNA production. Ten micrograms of total RNA was used
in the primer extension protocol with toxT primer as described
(16).
Introduction of Plasmids into V. cholerae. Plasmid pMT5 is
a broad host range plasmid in which a PCR-amplified fragment
of toxT, generated from classical strain 0395, was cloned as a
SalI-BamHI restriction fragment into pMMB66HE (17)
downstream of the isopropyl f3-D-thiogalactoside (IPTG)-
inducible tac promoter. pMT5 was mobilized from E. coli VM2
(18) into V cholerae by triparental plate mating with E. coli
MM294 carrying pRK2013, which supplies the mobilization
apparatus. V cholerae recipients of pMT5 were identified as
ampicillin-resistant cells on TCBS agar (Difco).
RESULTS
LB and AKI Growth of Classical and El Tor V. cholerae.
Production of CT and the TCP major subunit TcpA is readily
achieved with classical strains of V. cholerae by growth in LB
medium (pH 6.5-7.0) at 25-30°C. El Tor strains will not
produce these virulence factors when grown under the same
conditions but will do so under very strictly defined growth in
conditions termed AKI (refs. 11 and 12; Fig. 1). In AKI
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FIG. 1. TcpA and CT production by classical and El Tor strains.
0395 is a classical strain and E7946 and C6709 are El Tor strains.
Cultures were grown in the indicated media [LB represents cultures
grown overnight in Luria broth at 30°C and AKI represents growth
under conditions previously described (11).] Whole cell lysates were
prepared by boiling cell pellets in SDS/PAGE sample buffer. Aliquots
of the gels were subjected to SDS/PAGE in 15% gels and subsequently
electroblotted to nitrocellulose paper. These filters were probed with
anti-TCP antiserum as described (14). CT represents the amount of CT
detected in the supernatants of the cultures as measured by GM1-
ganglioside ELISA (15).
eral hours and then grown with vigorous aeration for several
hours more. As shown in Fig. 1, classical strain 0395 produced
high levels of CT and TcpA when grown in either LB or AKI,
although LB seemed the more favorable medium. In contrast,
the El Tor strains E7946 and C6709 produced detectable CT
and TcpA only under AKI conditions (Fig. 1).
Expression of ToxR in Classical and El Tor V. cholerae.
Because El Tor and classical strains differ so greatly in their
response to environmental signals, we considered it likely that
there is a difference in the ToxR/ToxT regulatory cascade
between the two biotypes. It is improbable that gross differ-
ences in ToxR account for biotype-specific virulence regula-
tion because the predicted coding sequence of toxR from
classical and El Tor strains differs at only a few residues, with
the changes conferring only conservative replacements (ref.
19; Fig. 2). We therefore considered the possibility that
expression of ToxR might be different in the two different
biotypes.
To address this, we performed immunoblot analysis using
ToxR-specific antiserum on extracts from cultures of V. chol-
erae classical and El Tor strains grown in LB or AKI media at
30°C. Fig. 3 shows that levels of ToxR in classical and El Tor
strains are equivalent and independent of the growth condi-
tions. An interesting point about this observation, which will
be discussed further below, is that while toxR expression per se
is sufficient to result in transcription of the ctxAB operon in the
heterologous host E. coli (18), it does not appear to be
sufficient for ctxAB expression in V. cholerae.
toxT Expression in Classical and El Tor Strains. Under
conditions permissive for virulence factor production by the
classical strains, a ToxR-dependent promoter controlling toxT
expression is active and appears to be required for subsequent
virulence factor production (16, 20). We performed primer
extension ofmRNA from an El Tor strain of V cholerae grown
under these same conditions with a primer specific for toxT to
determine whether the lack of CT and TcpA production in the
El Tor background might be correlated with a lack of toxT
expression. As seen in Fig. 4A, toxT-specific message is unde-
tectable from the El Tor strains C6706 and C6709 grown in
parallel with the classical strain 0395, from which toxTmRNA
can be observed. Analysis of the RNA used for the primer
extension confirmed that equivalent amounts of RNA were
analyzed in each reaction and that the El Tor mRNA is not
subject to a generally higher level of degradation compared
with the classical mRNA (Fig. 4B). We previously identified
two primer-extension products from toxT RNA mapping ex-
periments in wild-type classical V cholerae. One of these,
signified with an arrow in Fig. 3, is expressed from a ToxR-
regulated promoter preceding the toxT gene in the tcp gene
cluster (20). The other (Fig. 4A) can also be detected in toxR
mutant classical V cholerae (20) and its promoter has not been
identified. Whatever the precise mechanisms governing the
level of this transcript may be, it is clearly absent from the El
Tor strains grown for the experiment shown in Fig. 4A.
The precise mechanism by which growth conditions influ-
ence ToxR-regulated gene expression is not fully worked out.
In classical strains, elevated culture pH (8.5 versus 6.5) results
in dramatically reduced expression of toxT and, consequently,
of CT and TcpA (14, 16). This high-pH effect can be overcome,
even in the absence of ToxR, by overexpression of toxT from
a ToxR-independent promoter (14). By analogy we reasoned
that if the main difference in virulence regulation in the El Tor
strains is their lack of toxT expression when grown under
conditions permissive for such expression in classical strains,
then activation of toxT expression in the El Tor strains by an
exogenously regulated promoter might lead to expression of
ToxR regulated genes under non-AKI growth conditions.
This was tested by expressing toxT from the tac promoter,
which is induced in the presence of IPTG. When cultured in
the presence of IPTG, El Tor strains with the tac-toxT gene
7992 Microbiology: DiRita et al.
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FIG. 2. Predicted protein sequence of ToxR from V. cholerae El
underlined and the codon change is indicated in parentheses.
fusion in pMT5 produced high levels of CT and TcpA under
the same culture conditions favored by the classical strains
(Fig. 5). Without addition of IPTG, expression of these factors
was not observed (Fig. 5). To determine if the TcpA protein
produced upon the induction of toxT expression was incorpo-
rated into pili, tcpA + and tcpA deletion strains expressing toxT
from plasmid pMT5 were examined for the presence of TCP
by electron microscopy. As seen in Fig. 6, pili resembling TCP
were produced by the wild-type strain C6706str2 after over-
night growth with induction of toxT expression from pMT5,
while no such pili were seen in the tcpA deletion strain KHT52.
Occasional single flexible fibrils that did not resemble the rigid
structure of TCP were seen in the mutant. Thus, the produc-
tion of TcpA as determined by the immunoblot appears to
correlate with pilus production, suggesting that ToxT activates
the expression of all the genes in the tcp biogenesis operon,
similar to what is seen in classical biotype strains.
El Tor Strains Require toxT for Virulence Gene Expression.
One possibility for the altered regulation of ToxR controlled
genes in the El Tor background is that this biotype has a
pathway for expression of these genes that is independent of
ToxT. We investigated this possibility by analyzing CT and
TcpA expression in a toxT mutant derivative of El Tor strain
E7946. In this mutant, the wild-type copy of toxT has been
replaced with a mutant copy carrying an in-frame deletion of
93 bp predicted to encode a helix-turn-helix DNA binding
domain. (Complete characterization of this mutant will be
described in a separate report.)
Wild-type El Tor strain E7946 and its toxT mutant derivative
were grown in AKI conditions. Cell extracts were assayed by
immunoblot for TcpA production and culture supernatants
were assayed for CT (Fig. 7). Neither of these factors was
detectably produced in the toxT mutant strain, showing that
ToxT is required for their expression in El Tor V. cholerae as
it is in classical V. cholerae (unpublished results).
DISCUSSION
Expression of CT and TCP by the two major biotypes of V
cholerae, classical and El Tor, appears to be regulated differ-
ently by environmental signals in each biotype. Only when
grown in the specialized AKI growth medium is high-level CT
and pilus production by the El Tor biotype achievable, whereas
classical strains can produce these factors in a wide variety of
0395 JJM43 C6706 C6709
AKIILB AKI I LB AKI I LB AKI I LB
E7946
AKII LB
Tor strain E7946. Positions that differ from the classical protein (3) are
growth media, including AKI. Although they exhibit this
difference, both biotypes share a requirement for the ToxR
and ToxT regulatory proteins for toxin and pilus production.
In this report we have shown that removing toxT gene expres-
sion from its normal control is sufficient to broaden the range
of growth conditions in which the El Tor biotype of V. cholerae
can express toxin and pilus. This suggests that an important
difference between El Tor and classical V. cholerae is their
respective abilities to express the toxT gene. We assume that
the normal control of toxT in this biotype involves ToxR,
although this has not been formally proven. For the purposes
of the discussion that follows, this assumption holds.
There are other differences between the biotypes beside the
way they regulate toxin expression. El Tor strains produce a
fimbrial structure termed the mannose-sensitive hemaggluti-
nin (MSHA) that is not expressed by the majority of classical
strains (21). Antibodies directed against MSHA can block
colonization by El Tor strains in two different animal models,
showing that this structure is important in vivo (22). In addition
to MSHA, El Tor strains also produce a hemolysin not
expressed by classical strains. The role of this factor in viru-
lence has not been explained, but animal model experiments




FIG. 3. ToxR immunoblot of extracts from classical and El Tor V.
cholerae grown in LB or under AKI conditions. Strains 0395(toxR+)
and JJM43(toxR-) are classical biotype; strains C6706, C6709, and
E7946 are El Tor biotype.
FIG. 4. (A) toxTprimer extension ofRNA from V cholerae cultures
grown under conditions for high-level expression of the ToxR regulon
by classical strains (30°C, pH 7.0). The arrow points out the toxT
transcript that initiates from a ToxR-dependent promoter preceding
the toxT gene. Lanes: C, classical biotype; E, El Tor biotype. (B)
Ethidium-stained gel of the same RNA preparation used for primer-
extension reactions. Ten micrograms of RNA is loaded in each lane
and the strain designation is given above each lane.
Microbiology: DiRita et aL
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FIG. 5. TcpA and CT production in El Tor strains E7946 and
C6709 expressing toxT under the control of the tac promoter in plasmid
pMT5. TcpA and CT from classical strain 0395 are shown as well.
Cultures were grown in LB with or without addition of 1 mM IPTG,
as indicated.
be important for successful colonization by El Tor strains (23,
24). Production ofvirulence-associated factors like MSHA and
hemolysin by El Tor strains distinguishes them from classical
strains in important ways and may play a role in the differences
observed in the epidemic nature of El Tor and classical
biotypes (see below), but the sine qua non of disease caused by
either biotype is the ability to produce CT. Our results show
that the control of toxin production by the ToxR/ToxT system
in each biotype is different.
That ToxT is required for virulence gene expression in the
El Tor biotype (Fig. 7) rules out the possibility that biotype-
specific virulence control is associated with gross differences
in the virulence regulatory schemes of the two biotypes. It also
suggests that the previous demonstration of a requirement for
ToxR in the El Tor biotype (13) most likely relates to its role
in activating toxT expression, as postulated for the classical
biotype (8). One question raised by our work, however, is the
role of ToxR in ctxAB transcription in V cholerae. Both ToxR
and ToxT, independently of each other, can activate a ctx: :lacZ
fusion in E. coli to high levels (14, 18). Transcription of
ctx-lacZ in E. coli initiates at the same site with each activator,
and this is the site at which ctxAB transcription initiates in V
cholerae (G. Champion, M.N., and V.J.D., unpublished work).
Nevertheless, El Tor strains do not produce CT under non-
AKI growth conditions even though ToxR is expressed at
levels similar to what is observed under AKI growth conditions
(Fig. 3). That this is not simply due to a requirement for a signal
FIG. 6. Comparison of pilus production after induction of toxT
expression in wild-type and tcpA deletion El Tor biotype strains.
Parental strain C6706str2 carrying pMT5 (toxT+) (A) and tcpA
deletion strain KHT52 also carrying pMT5 (B) were grown overnight
in LB with ampicillin at 37°C in the presence of 0.05 mM IPTG to
induce toxT expression. Samples were visualized by electron micros-




FIG. 7. CT and TcpA production in wild-type El Tor strain E7946
and its toxT mutant derivative grown under AKI conditions.
provided by AKI growth to cause ToxR to activate transcrip-
tion of ctxAB is shown by the fact that the toxT mutant
derivative of El Tor strain E7946 does not produce CT under
AKI growth (Fig. 7). This result suggests that, at least in vitro,
the activation of ctxAB expression is due solely to ToxT in El
Tor V. cholerae. This also appears to be the case for classical
biotype V. cholerae (G. Champion, M.N., and V.J.D., unpub-
lished results).
The work in this report supports a model in which activation
oftoxTby ToxR is under biotype-specific control in V. cholerae.
Previous work has demonstrated that ToxR alone is insuffi-
cient for activation of the classical toxT promoter (20). It
therefore seems that another factor may be involved in acti-
vating toxT. If this were the case, then the most appealing
model for biotype-specific gene regulation would be that this
factor is active only under AKI conditions in the El Tor biotype
but is active in a broader range of growth conditions in the
classical biotype.
The level of asymptomatic V cholerae infection is higher
with El Tor strains than with. classical strains, suggesting that
the pathogenicity of El Tor strains is reduced compared with
that of classical strains (3). Ewald (25, 26) suggests that
displacement of classical V. cholerae by the El Tor biotype may
have occurred due to improvements in the quality of drinking
water in endemic areas. The basis for this is his hypothesis that
a higher level of virulence should be seen in a gastrointestinal
pathogen that is likely to be subject to waterborne transmission
and that, conversely, a gastrointestinal pathogen less likely to
be transmitted solely via contaminated drinking water should
evolve to lower virulence (25, 26). This hypothesis is based on
retrospective data showing a correlation between waterborne
transmission and the virulence (measured by mortality rate) of
the causative strain. When looked at in this retrospective way,
the most virulent gastointestinal pathogen is the classical
biotype of V. cholerae (26) and El Tor V. cholerae are consid-
erably less virulent. As intriguing as this hypothesis is, it suffers
from not being based on controlled prospective studies and it
also does not account for the alternating displacement of
classical and El Tor strains in one geographic locale such as has
occurred in Bangladesh over the past 25 years (27). Neverthe-
less, if the history of interaction between V cholerae and
human populations indeed resulted in the decreased severity
of the El Tor biotype compared with the classical biotype, it is
logical to consider that the target of this natural selection
might have been the control of toxin production. The results
we report herein suggest that a difference in toxin regulation
exists between the two biotypes; the selection pressures that
may have caused this difference remain unclear.
This paper is dedicated to the memory of Gunhild Jonson, who
made pioneering contributions toward understanding El Tor V. chol-






7994 Microbiology: DiRita et al.
Proc. Natl. Acad. Sci. USA 93 (1996) 7995
comments regarding this work and Gretchen Champion for technical
assistance in constructing the El Tor toxT mutant. R.K.T. thanks Paul
Rubinton for technical assistance and Louisa Howard for assistance
with the electron microscopy. This work was supported by Grants Al
31645 (to V.J.D.) and Al 25096 (to R.K.T.) from the National
Institutes of Health and JFRA 392 (to V.J.D.) and NP 824 (to R.K.T.)
from the American Cancer Society. M.N. is a trainee of Cellular
Biotechnology Training Grant GM 08353 from the National Institutes
of Health. P.M.B. was a trainee of Molecular Pathogenesis Training
Grant Al 07360 from the National Institutes of Health. DNA sequence
analysis work was supported in part from Grant M01 RR-00042 to the
Clinical Research Center at the University of Michigan.
1. Blake, P. A. (1994) in Vibrio cholerae and Cholera: Molecular to
Global Perspectives, eds. Wachsmuth, I. K., Blake, P. A. & Olsvik,
0. 0. (Am. Soc. for Microbiol., Washington, DC), pp. 293-296.
2. Hall, R. H., Khambaty, F. M., Kothary, M. & Keasler, S. P.
(1993) Lancet 342, 430.
3. Kaper, J. B., Morris, J. G., Jr., & Levine, M. M. (1995) Clin.
Microbiol. Rev. 8, 48-86.
4. Herrington, D. A., Hall, R. H., Losonsky, G., Mekalanos, J. J.,
Taylor, R. K. & Levine, M. M. (1988) J. Exp. Med. 168, 1487-
1492.
5. Taylor, R. K., Miller, V. L., Furlong, D. B. & Mekalanos, J. J.
(1987) Proc. Natl. Acad. Sci. USA 84, 2833-2837.
6. Kaufman, M. R., Shaw, C. E., Jones, I. D. & Taylor, R. K. (1993)
Gene 126, 43-49.
7. Iredell, J. R. & Manning, P. A. (1994) Trends Microbiol. 2,
187-192.
8. DiRita, V. J. (1992) Mol. Microbiol. 6, 451-458.
9. Peterson, K. M. & Mekalanos, J. J. (1988) Infect. Immun. 56,
2822-2829.
10. Miller, V. L. & Mekalanos, J. J. (1988) J. Bacteriol. 170, 2575-
2583.
11. Iwanaga, M., Nakasone, N. & Ehara, M. (1989) Microbiol.
Immunol. 33, 1-9.
12. Jonson, G., Svennerholm, A. M. & Holmgren, J. (1990) FEMS
Microbiol. Ecol. 74, 221-228.
13. Waldor, M. K. & Mekalanos, J. J. (1994) Infect. Immun. 62,
72-78.
14. DiRita, V. J., Parsot, C., Jander, G. & Mekalanos, J. J. (1991)
Proc. Natl. Acad. Sci. USA 88, 5403-5407.
15. Svennerholm, A. M. & Holmgren, J. (1978) Curr. Microbiol. 1,
19-23.
16. Higgins, D. E., Nazareno, E. & DiRita, V. J. (1992) J. Bacteriol.
174, 6974-6980.
17. Morales, V. M., Backman, A. & Bagdasarian, M. (1991) Gene 97,
39-47.
18. Miller, V. L. & Mekalanos, J. J. (1984) Proc. Natl. Acad. Sci. USA
81, 3471-3475.
19. Miller, V. L., Taylor, R. K. & Mekalanos, J. J. (1987) Cell 48,
271-279.
20. Higgins, D. E. & DiRita, V. J. (1994) Mol. Microbiol. 14, 17-29.
21. Jonson, G., Lebens, M. & Holmgren, J. (1994) Mol. Microbiol. 13,
109-118.
22. Osek, J., Svennerholm, A. M. & Holmgren, J. (1992) Infect.
Immun. 60, 4961-4964.
23. Williams, S. G. & Manning, P. A. (1991) Mol. Microbiol. 5,
2031-2038.
24. Alm, R. A. & Manning, P. A. (1990) Mol. Microbiol. 4, 413-425.
25. Ewald, P. W. (1993) Sci. Am. 268, 86-93.
26. Ewald, P. W. (1991) Epidemiol. Infect. 106, 83-119.
27. Sun, D., Mekalanos, J. J. & Taylor, R. K. (1990)J. Infect. Dis. 161,
1231-1236.
28. Jonson, G., Holmgren, J. & Svennerholm, A. (1992) Infect.
Immun. 60, 4278-4284.
Microbiology: DiRita et al.
